Recruiting Atrial Fibrillation Studies in Kansas City
About Atrial Fibrillation Clinical Trials in Kansas City
Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.
There are currently 1 atrial fibrillation clinical trials recruiting participants in Kansas City, MO. These studies are seeking a combined 240 participants. Research is being sponsored by Incyte Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atrial Fibrillation Clinical Trials in Kansas City — FAQ
Are there atrial fibrillation clinical trials in Kansas City?
Yes, there are 1 atrial fibrillation clinical trials currently recruiting in Kansas City, MO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Kansas City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.
Are clinical trials in Kansas City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.
What atrial fibrillation treatments are being tested?
The 1 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.
Data updated March 2, 2026 from ClinicalTrials.gov